Beam Therapeutics Inc. (BEAM) Reviews Initial Phase I II BEAM-301 Data in Glycogen Storage Disease Type 1a - Slideshow

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 27 Oct 2026, 17:10 UTC. 2 material updates are listed in the timeline. The headline in use is “Beam Therapeutics Inc. (BEAM) Reviews Initial Phase I II BEAM-301 Data in Glycogen Storage Disease Type 1a - Slideshow”. This note is SignalsMonitor's own briefing, not the publisher's article.